It is a leading brand of imported calcium that is easily absorbed, which has been leading in sales volume for five consecutive years. Over the past 20 years, we have been committed to providing global consumers with high-quality and safe calcium products made from high-quality calcium sources of the United States.

Containing dimeticone, it is a drug which can fully supplement pancreatic enzymes, effectively promote choleresis, quickly eliminate abdominal distension, and effectively relieve indigestion symptoms such as anepithymia, abdominal discomfort, early satiety, belching, fatty stool, chemical indigestion, etc.

As a category B drug, it has been included in the National Reimbursement Drug List (NRDL). With the level I medical evidence, it is the first anti-hepatic fibrosis therapeutic drug recommended in the Six Major Guidelines/Consensuses, and also the first Chinese patent drug for treatment of hepatopathy for which Phase II clinical trials have been completed in the United States upon approval by the FDA. Substantial clinical evidences show that Fuzhenghuayu has the efficacy of preventing and treating hepatic fibrosis and liver cirrhosis, and reducing the risk of liver cancer.

The new metformin is an osmotic pump-controlled release preparation, which can stabilize the blood concentration throughout the day due to the action of release at almost a constant speed. Although taken once a day, it has a long-lasting curative effect but less gastrointestinal side effects, which can reduce blood glucose stably.

Having lean quality, it can stably reduce blood pressure. Having passed the consistency evaluation, the high-quality Nifedipine Controlled-release Tablets are used for treatment of hypertension and coronary heart disease.

Nutrasumma is an American brand specialized in the development and production of natural, organic, high-potency dietary supplements.

Originated from an important invention made in a Japanese medical laboratory, the micro-needle eye mask applying the "transdermal drug delivery technology” enables the users to enjoy medical-grade care services at home. Medical evidences show that it is safe and effective, and users do not need to worry about trauma, pain, escharosis and reconstruction. With more than 40 patents, it has a high efficacy despite of simple ingredients, which can effectively relieve the symptoms such as dark circles, fine lines around the eyes, etc.

This cosmetic product is developed by Sato, a leading brand of medical skin care in Japan. It features the unique basal repair components, and the use of DDS drug slow-release osmosis technology, Sato’s exclusive ointment technology, and plant essence extraction and mixing technology. It enables the skin care from base, which can explore the potential of skin cells, and exude a healthy beauty from inside to outside.

TRANSINO is a comprehensive stain care brand owned by Daiichi Sankyo, a pharmaceutical group established over a century ago. TRANSINO focuses on the research of "Tranexamic Acid" with its effect in reducing melanin synthesis and dark spots in skin. Based its research on the validation of skin science, it offers multiple treatments to skin problems like dark spots, dry and rough skin problems, and helps to reproduce superior beauty.

Picky CAT is a shop-in-shop solution provided by Baheal Medical to improve the efficiency of cooperative stores. With the tenet of "rejecting invalidity, strict selection and practical effectiveness", by carefully selecting effective skin care products that have been clinically proven globally, Baheal Picky CAT provides consumers with personalized solutions to skin problems. At present, it has reached strategic cooperation with many well-known companies such as CosMED Pharmaceutical, Sato Pharmaceutical, Daiichi Sankyo Pharmaceutical, Xi'an Giant Biogene, etc., and has landed hundreds of cosmetics boutique chains, pharmacy chains and mother and baby chains across the country, which has received positive responses from the market.